| Title: |
Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone Marrow |
| Authors: |
Swerts, Katrien; Ambros, Peter F.; Brouzes, Chantal; Navarro, José M. Fernandez; Gross, Nicole; Rampling, Dyanne; Schumacher-Kuckelkorn, Roswitha; Sementa, Angela R.; Ladenstein, Ruth; Beiske, Klaus |
| Source: |
Journal of Histochemistry & Cytochemistry ; volume 53, issue 12, page 1433-1440 ; ISSN 0022-1554 1551-5044 |
| Publisher Information: |
SAGE Publications |
| Publication Year: |
2005 |
| Description: |
Standard cytomorphological examination of bone marrow (BM) aspirates does not appear to be sensitive enough to detect single neuroblastoma cells. The SIOPEN Neuroblastoma Bone Marrow Committee developed a sensitive and reproducible anti-GD2 immunocytochemical assay and introduced morphological and immunocytological criteria for the interpretation of results. Fixed cytospins were incubated with a commercially available anti-GD2 monoclonal antibody and an APAAP kit. Cells fulfilling all morphological and immunocytological criteria were called criteria-positive cells (CPCs). Not convincingly interpretable cells fulfilled some, but not all, criteria, and negative cells displayed only exclusion criteria. The genetic profile of doubtful cells was checked by fluorescence in situ hybridization. Ideally, 3 × 10 6 cells were analyzed to reach a 95% probability of detecting one tumor cell in 1 × 10 6 mononuclear cells. Four quality control rounds were organized to validate the method. A total of 111 quality control samples were analyzed. Two main improvements were achieved: in discordant cases, the range between the lowest and highest reported result was reduced by half, and discordant results were only found in samples with less than 10 CPCs per 1 × 10 6 . This article describes the first internationally standardized protocol to detect and quantify rare neuroblastoma cells by immunocytochemistry. This method is an indispensable tool for multicenter studies evaluating the clinical significance of minimal residual disease in neuroblastoma. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1369/jhc.5c6661.2005 |
| DOI: |
10.1369/jhc.5C6661.2005 |
| Availability: |
https://doi.org/10.1369/jhc.5c6661.2005; https://journals.sagepub.com/doi/pdf/10.1369/jhc.5C6661.2005; https://journals.sagepub.com/doi/full-xml/10.1369/jhc.5C6661.2005 |
| Rights: |
https://journals.sagepub.com/page/policies/text-and-data-mining-license |
| Accession Number: |
edsbas.DECCC48A |
| Database: |
BASE |